Zhange Li

2.0k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Zhange Li is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zhange Li has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zhange Li's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Zhange Li is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Zhange Li collaborates with scholars based in China, Australia and Russia. Zhange Li's co-authors include Yong Zhang, Baofeng Yang, Chaoqian Xu, Huan Yang, Xue Bai, Xin Liu, Jiamin Li, Xianxian Wu, Lin Yuan and Haiying Zhang and has published in prestigious journals such as Scientific Reports, Cell Death and Differentiation and European Journal of Pharmacology.

In The Last Decade

Zhange Li

17 papers receiving 1.5k citations

Hit Papers

Nicotine promotes atherosclerosis via ROS-NLRP3-mediated ... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhange Li China 16 1.1k 404 296 156 152 17 1.5k
Xianxian Wu China 17 832 0.8× 372 0.9× 277 0.9× 123 0.8× 211 1.4× 45 1.4k
Qin Chen China 21 1.0k 1.0× 520 1.3× 164 0.6× 99 0.6× 146 1.0× 78 1.8k
Song‐Yang Zhang China 21 754 0.7× 216 0.5× 322 1.1× 73 0.5× 199 1.3× 32 1.6k
Xiaoyu Liu China 22 710 0.7× 231 0.6× 193 0.7× 139 0.9× 155 1.0× 58 1.5k
Giovanni Tossetta Italy 29 750 0.7× 233 0.6× 300 1.0× 41 0.3× 116 0.8× 65 1.7k
Naijin Zhang China 22 730 0.7× 223 0.6× 143 0.5× 200 1.3× 95 0.6× 71 1.3k
Zhen Qiu China 14 784 0.7× 195 0.5× 165 0.6× 125 0.8× 146 1.0× 38 1.2k

Countries citing papers authored by Zhange Li

Since Specialization
Citations

This map shows the geographic impact of Zhange Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhange Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhange Li more than expected).

Fields of papers citing papers by Zhange Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhange Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhange Li. The network helps show where Zhange Li may publish in the future.

Co-authorship network of co-authors of Zhange Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhange Li. A scholar is included among the top collaborators of Zhange Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhange Li. Zhange Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yin, Hang, Lin Chen, Yiru Wang, et al.. (2021). M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway. Cell Death and Differentiation. 30(3). 605–617. 99 indexed citations
2.
Li, Zhange, Honglin Xu, Xin Liu, et al.. (2020). GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3. Cell Death and Disease. 11(10). 917–917. 59 indexed citations
3.
Jiao, Lei, Yingchun Shao, Qi Yu, et al.. (2020). GDF11 replenishment protects against hypoxia-mediated apoptosis in cardiomyocytes by regulating autophagy. European Journal of Pharmacology. 885. 173495–173495. 15 indexed citations
4.
Qin, Wei, Longyin Zhang, Zhange Li, et al.. (2020). Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis. Theranostics. 10(12). 5276–5289. 35 indexed citations
5.
Xiao, Dan, Yue Zhang, Rui Wang, et al.. (2019). Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3. Acta Pharmaceutica Sinica B. 9(4). 724–733. 45 indexed citations
6.
Qin, Wei, Longyin Zhang, Zhange Li, et al.. (2019). Metoprolol protects against myocardial infarction by inhibiting miR-1 expression in rats. Journal of Pharmacy and Pharmacology. 72(1). 76–83. 15 indexed citations
7.
Qin, Wei, Longyin Zhang, Zhange Li, et al.. (2019). SIRT6-mediated transcriptional suppression of MALAT1 is a key mechanism for endothelial to mesenchymal transition. International Journal of Cardiology. 295. 7–13. 21 indexed citations
8.
Hu, Yingying, Xi Chen, Zhange Li, et al.. (2019). MicroRNA‑1 downregulation induced by carvedilol protects cardiomyocytes against apoptosis by targeting heat shock protein 60. Molecular Medicine Reports. 19(5). 3527–3536. 16 indexed citations
9.
Li, Qiang, Zhange Li, Lin Yuan, et al.. (2019). High glucose promotes hepatic fibrosis via miR‑32/MTA3‑mediated epithelial‑to‑mesenchymal transition. Molecular Medicine Reports. 19(4). 3190–3200. 14 indexed citations
10.
Xiao, Dan, Tong Zhou, Yujie Fu, et al.. (2018). MicroRNA-17 impairs glucose metabolism in insulin-resistant skeletal muscle via repressing glucose transporter 4 expression. European Journal of Pharmacology. 838. 170–176. 25 indexed citations
11.
Xiao, Dan, Yingying Hu, Yujie Fu, et al.. (2018). Emodin improves glucose metabolism by targeting microRNA-20b in insulin-resistant skeletal muscle. Phytomedicine. 59. 152758–152758. 33 indexed citations
12.
Wu, Xianxian, Haiying Zhang, Wei Qi, et al.. (2018). Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death and Disease. 9(2). 171–171. 467 indexed citations breakdown →
13.
Zhang, Yong, Xin Liu, Xue Bai, et al.. (2017). Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR‐223/NLRP3 axis. Journal of Pineal Research. 64(2). 348 indexed citations
14.
Zhang, Yong, Xianxian Wu, Yang Li, et al.. (2016). Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis. Scientific Reports. 6(1). 33787–33787. 47 indexed citations
15.
Zhang, Tianze, Yingying Hu, Jin Ju, et al.. (2016). Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D. Scientific Reports. 6(1). 19346–19346. 47 indexed citations
16.
Hu, Yingying, Li Zhang, Xianxian Wu, et al.. (2016). Bisphenol A, an environmental estrogen-like toxic chemical, induces cardiac fibrosis by activating the ERK1/2 pathway. Toxicology Letters. 250-251. 1–9. 49 indexed citations
17.
Zhang, Yong, Wei Qin, Longyin Zhang, et al.. (2015). MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis. Scientific Reports. 5(1). 9401–9401. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026